过去一年中添加的文章,按日期排序

The safety and feasibility of adjuvant immunotherapy with autologous cytokine-induced killer cells for patients with hepatocellular carcinoma beyond Milan criteria after …

G Hong, J Yang, KS Suh, JM Kim, KW Lee, NJ Yi - Korean Journal of … - KoreaMed
58 天前 - Adjuvant immunotherapy with autologous cytokine-induced killer (CIK) cells has
shown promise postsurgery, yet research concerning hepatocellular carcinoma (HCC) patients …